VIGIL - Use of PCR-SARS-CoV-2 in Children (VIGIL)

Head :
JUNG Camille

Last update : 05/05/2021 | Version : 1 | ID : 73890

print
Print
xml
XML

Export to XML

Please choose the format :

pdf
PDF
xml
CSV (Excel)

Export to CSV

What sections do you want to export ?

Métadonnées
Identification
General Aspects
Scientific investigator(s) (Contact)
Collaborations
Funding
Governance of the database
Additional contact
Type of database
Database objective
Population type
Dates
Size of the database
Data
Procedures
Promotion
Access
Select all | Invert selection | No selection

Which version do you want to export ?

send
Send
General
Identification
Detailed name Use of PCR-SARS-CoV-2 in Children (VIGIL)
Sign or acronym VIGIL
CNIL registration number, number and date of CPP agreement, AFSSAPS (French Health Products Safety Agency) authorisation NCT04412317
General Aspects
Medical area Infectious diseases
Study in connection with Covid-19 Yes
Scientific investigator(s) (Contact)
Name of the director JUNG
Surname Camille
Email camille.jung@chicreteil.fr
Collaborations
Participation in projects, networks and consortia Yes
Funding
Governance of the database
Sponsor(s) or organisation(s) responsible Créteil Intermunicipal Hospital
Organisation status Public
Presence of scientific or steering committees Yes
Additional contact
Name of the contact LEVY
Surname Corinne
Email corinne.levy@activ-france.fr
Organization ACTIV
Main features
Type of database
Type of database Study databases
Study databases (details) Cohort study
Database recruitment is carried out by an intermediary A selection of health care professionals
Database recruitment is carried out as part of an interventional study No
Database objective
Main objective Percentage of patients positive for Covid-19
Inclusion criteria Children <15 years
indication for PCR or rapid antigen test for Covid-19
Population type
Age Newborns (birth to 28 days)
Infant (28 days to 2 years)
Early childhood (2 to 5 years)
Childhood (6 to 13 years)
Adolescence (13 to 18 years)
Population covered General population
Pathology
Gender Male
Woman
Geography area National
Data collection
Dates
Size of the database
Size of the database (number of individuals) [500-1000[ individuals
Data
Database activity Current data collection
Type of data collected Clinical data
Paraclinical data
Presence of a biobank No
Procedures
Followed pathology
Promotion and access
Promotion
Access

Partners - FAQ - Contact - Site map - Legal notices - Administration - Updated on December 15 2020 - Version 4.10.05

View Edit Create here